Coffee consumption vs. cancer risk - a review of scientific data

• Autorzy: Wierzejska R.
• Języki publikacji: EN

Abstrakty

EN

Coffee and its impact on health continue to be the topic of much heated debate. Until recently, coffee consumption has been believed to be associated with adverse effects, mainly cardiovascular problems. However, the vast majority of contemporary sources not only emphasize a lack of detrimental effect, but also suggest a beneficial effect of coffee intake. According to the current state of knowledge, coffee consumption is not associated with the majority of cancers although the results of studies on bladder and lung cancer remain conflicting. In case of colorectal, liver and breast cancers, coffee drinking may even have a protective effect. Coffee contains numerous compounds, potentially beneficial as well as harmful. The former include polyphenols which inhibit harmful oxidation processes in the body, while the latter include acrylamide, whose high intake in daily diet may have carcinogenic action. The impact of coffee on the human body is associated also with other factors, e.g. the rate of metabolism and other individual features.

PL

Od lat trwa dyskusja na temat wpływu picia kawy na zdrowie. Jeszcze do niedawna przeważały poglądy o jej negatywnych skutkach, w tym przede wszystkim w postaci zwiększonego ryzyka chorób sercowo-naczyniowych. W ostatnich latach większość publikacji naukowych podkreśla jednak brak szkodliwego wpływu picia kawy na zdrowie, a niektóre sugerują nawet jej działanie prozdrowotne. W świetle aktualnego stanu wiedzy obecność kawy w diecie nie ma związku z zachorowaniem na większość nowotworów. Niejednoznaczne są dane dotyczące nowotworów pęcherza moczowego i płuc, natomiast w przypadku jelita grubego, wątroby i piersi nie wyklucza się jej działania ochronnego. Kawa zawiera szereg składników, zarówno potencjalnie korzystnych, jak i szkodliwych. Do pierwszej grupy należą przede wszystkim polifenole, hamujące szkodliwe procesy utleniania w organizmie. Do drugiej należy zaliczyć akryloamid, którego duże spożycie może mieć działanie kancerogenne. Wpływ kawy na organizm człowieka może zależeć także od innych czynników, w tym szybkości jej metabolizmu i innych cech osobniczych.

Słowa kluczowe

EN

coffee; consumption; human nutrition; cancer; disease risk; scientific data; human health

• Wydawca: -
• Czasopismo: Roczniki Państwowego Zakładu Higieny
• Rocznik: 2015
• Tom: 66
• Numer: 4
• Opis fizyczny: p.293-298,ref.

Twórcy

autor

Wierzejska R.

• Department of Nutrition and Dietetetics with Clinic of Metabolic Diseases and Gastroenterology, National Food and Nutrition Institute, Powsinska street 61/63, 02-903 Warsaw, Poland

Bibliografia

• 1. Arab L.: Epidemiologic evidence on coffee and cancer. Nutr Cancer. 2010; 62(3): 271-283.
• 2. Ayari I., Fedeli U., Saguem S., Hidar S., Khlifi S., Pavanello S.: Role of CYP1A2 polymorphisms in breast cancer risk in women. Mol Med Rep. 2013; 7(1): 280- 286.
• 3. Baker J.A., McCann S.E., Reid M.E., Nowell S., Beehler G.P., Moysich K.B.: Association between black tea and coffee consumption and risk of lung cancer among current and former smokers. Nutr Cancer. 2005; 52(1): 15-21.
• 4. Bågeman E., Ingvar C., Rose C., Jernström H.: Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status. Cancer Epidemiol Biomarkers Prev. 2008; 17(4): 895- 901.
• 5. Bravi F., Bosetti C., Tavani A., Gallus S., La Vecchia C.: Coffee reduced risk for hepatocellular carcinoma: an updated meta-analysis. Clin Gastroenterol Hepatol. 2013; 11(11): 1413-1421.
• 6. Bøhn S.K., Blomhoff R., Paur I.: Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Mol Nutr Food Res. 2014; 58: 915-930.
• 7. Cao S., Liu L., Yin X., Wang Y., Liu J., Lu Z.: Coffee consumption and risk of prostate cancer: a meta-analysis of prospective cohort studies. Carcinogenesis. 2014; 35(2): 256-261.
• 8. Dong J., Zou J., Yu X.F.: Coffee drinking and pancreatic cancer risk: a meta-analysis of cohort studies. World J Gastroenterol. 2011; 17(9): 1204-1210.
• 9. Fagherazzi G., Touillaud M.S., Boutron-Ruault M.C., Clavel-Chapelon F., Romieu I.: No association between coffee, tea or caffeine consumption and breast cancer risk in a prospective cohort study. Public Health Nutr. 2011; 14(7): 1315-1320.
• 10. Galeone C., Turati F., La Vecchia C., Tavani A.: Coffee consumption and risk of colorectal cancer: a meta-analysis of case-control studies. Cancer Causes Control. 2010; 21(11): 1949-1959.
• 11. Ganmaa D., Wiolett W.C., Li T.Y., Feskanich D., van Dam R.M., Lopez-Garcia E., Hunter D.J., Holmes M.D.: Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer. 2008; 122, 9: 2071-2076.
• 12. Giovannucci E.: Meta-analysis of coffee consumption and risk of colorectal cancer. Am J Epidemiol. 1998; 147(11): 1043-1052.
• 13. Goodman M.T., Tung K.H., McDuffie K., Wilkens L.R., Donlon T.A.: Association of caffeine intake and CYP1A2 genotype with ovarian cancer. Nutr Cancer. 2003; 46(1): 23-29.
• 14. Hermansen K., Krogholm K.S., Bech B.H., Dragsted L.O., Hyldstrup L., Jørgensen K., Larsen M.L., Tjønneland A.M.: Coffee can protect against disease. Ugeskr Laeger. 2012; 174(39): 2293-2297.
• 15. Jarosz M., Wierzejska R., Siuba M.: Maternal caffeine intake and its effect on pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol. 2012; 160: 156-160.
• 16. Je Y., Liu W., Giovannucci E.: Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies. Int J Cancer. 2009; 124(7): 1662-1668.
• 17. Jernström H., Henningson M., Johansson U. Olsson H.: Coffee intake and CYP1A2 *1F genotype predict breast volume in young women: implications for breast cancer. Br J Cancer. 2008; 99(9): 1534-1538.
• 18. Jiang W.,Wu Y., Jiang X.: Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies. Gynecol Oncol. 2013; 129(3): 620-629.
• 19. Kosicka T., Kara-Perz H., Głuszek J.: Kawa – zagrożenie czy ochrona. Przewodnik lekarza. 2004; 69(9): 78-83.
• 20. Kostopoulos J., Ghadirian P., El-Sohemy A., Lynch H.T., Snyder C., Daly M., Domchek S., Randall S., Karlan B., Zhang P., Zhang S., Sun P. Narod S.A.: The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2007; 16(5): 912-916.
• 21. Landi M.T., Sinha R., Lang N.P., Kadlubar F.F.: Human cytochrome P4501A2. IARC Sci Publ. 1999; 148: 173- 195.
• 22. Larsson S.C., Wolk A.: Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology. 2007; 132(5): 1740-1745.
• 23. Li G., Ma D., Zhang Y., Zheng W., Wang P.: Coffee consumption and risk of colorectal cancer: a meta-analysis of observational studies. Public Health. 2013; 16(2): 346-357.
• 24. Li J., Seibold P., Chang-Claude J., Flesch-Janys D., Liu J., Czene K., Humphreys K., Hall P.: Coffee consumption modifies risk of estrogen-receptor negative breast cancer. Breast Cancer Res. 2011; 13(3): 49.
• 25. Lipworth L., Sonderman J.S., Tarone R.E., McLaughlin J.K.: Review of epidemiologic studies of dietary acrylamide intake and the risk of cancer. Eur J Cancer Prev. 2012; 21(4): 375-386.
• 26. Liu H., Hu G.H., Wang X.C., Huang T.B., Xu L., Lai P., Guo Z.F., Xu Y.F.: Coffee consumption and prostate cancer risk: a meta-analysis of kohort studies. Nutr Cancer. 2015; 67(3): 392-400.
• 27. Lopez-Garcia E., Rodrigues-Artalejo F., Li T.Y., Mukamal K.J., Hu F.B., van Dam R.M.: Coffee consumption and mortality in women with cardiovascular disease. Am J Clin Nutr. 2011; 94: 218-224.
• 28. Lowcock E.C., Cotterchio M., Anderson L.N., Boucher B.A., El-Sohemy A.: High coffee intake, but no caffeine is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype. Nutr Cancer. 2013; 65(3): 398-409.
• 29. Masterton G.S., Hayes P.C.: Coffee and liver: a potential treatment for liver disease? Eur J Gastroenterol Hepatol. 2010; 22(11): 1277-1283.
• 30. Mojska H., Gielecińska I.: Studies of acrylamide level in coffee and coffee substitutes: influence of row material and manufacturing conditions. Rocz Panstw Zakl Hig. 2013; 64(3): 173-181.
• 31. Mostofsky E., Rice M.S., Levitan E.B., Mittleman M.A.: Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis. Cric Heart Fail. 2012; 5: 401-405.
• 32. Nkondjock A., Ghadirian P., Kostopoulos J., Lubinski J., Lynch H.T., Kim-Sing C., Horsman D., Rosen B., Isaacs C., Weber B., Foulkes W., Ainsworth P., Tung N., Essen A., Friedman E., Eng C., Sun P., Narod S.A.: Coffee consumption and breast cancer among BRCA1 and BRCA2 mutation carriers. Int J Cancer. 2006; 118(1): 103-107.
• 33. Nomura A., Heilbrun L.K., Stemmermann G.N.: Prospective study of coffee consumption and risk of cancer. J Natl Cancer Inst. 1986; 76(4): 587-590.
• 34. Park C.H., Myung S.K., Kim T.Y., Seo H.G., Jeon Y.J., Kim Y.: Coffee consumption and risk of prostate cancer: a meta-analysis of epidemiological studies. BJU Int. 2010; 106(6): 762-769.
• 35. Pelucchi C., La Vecchia C., Bosetti C., Boyle P., Boffetta P.: Exposure to acrylamide and human cancer – a review and meta-analysis epidemiologic studies. Ann Oncol. 2011; 22(7): 1487-1499.
• 36. Rice J.M.: The carcinogenicity of acrylamide. Mutation Research. 2005; 580: 3-20.
• 37. Sang L.X., Chang B., Li X.H., Jiang M.: Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis. BMC Gastroenterol. 2013; 13, 34.
• 38. Snowdon D.A., Phillips R.L.: Coffee consumption and risk of fatal cancers. Am J Public Health. 1984; 74(8): 820-823.
• 39. Sobel W., Bond G.G., Parsons T.W., Brenner F.E.: Acrylamide cohort mortality study. Br. J. Ind. Med. 1986; 43: 785–788.
• 40. Tang N., Wu Y., Ma J., Wang B., Yu R.: Coffee consumption and risk of lung cancer: a meta-analysis. Lung Cancer. 2010; 67(1): 17-22.
• 41. Tang N., Zhou B., Wang B., Yu R.: Coffee consumption and risk of breast cancer: a meta-analysis. Am J Obstet Gynecol. 2009; 200(3): 290-299.
• 42. Tavani A., La Vecchia C.: Coffee and cancer: a review of epidemiological studies 1990-1999. Eur J Cancer. 2000; 9(4): 241-256.
• 43. Tian C., Wang W., Hong Z., Zhang X.: Coffee consumption and risk of colorectal cancer: a dose-response analysis of observational studies. Cancer Causes Control. 2013; 24: 1265-1268.
• 44. Torres D.M., Harrison S.A: Is it time to write a prescription for coffee? Coffee and liver disease. Gastroenterology. 2013; 144(4): 670-672.
• 45. Tuomilehto J.: Coffee and Heath. Duodecim. 2013; 129(13): 1398-1405.
• 46. Turati F., Galeone C., Edefonti V., Ferraroni M., Lagiou P., La Vecchia C., Tavani A.: A meta-analysis of coffee consumption and pancreatic cancer. Ann Oncol. 2012; 23(2): 311-318.
• 47. Vatten L.J., Solvoll K., Løken E.B.: Coffee consumption and risk of breast cancer. A prospective study of 14,593 Norwegian women. Br J Cancer. 1990; 62(2): 267-270.
• 48. Wang Y, Yu X., Wu Y.: Coffee and tea consumption and risk of lung cancer: a dose-response analysis of observational studies. Lung Cancer. 2012; 78: 167-170.
• 49. Wierzejska R.: Kofeina - powszechny składnik diety i jej wpływ na zdrowie. Rocz Panstw Zakl Hig 2012; 63(2): 141-147.
• 50. Wilson K.M., Giovannucci E., Stampfer M.J., Mucci L.A.: Dietary acrylamide and risk of prostate cancer. Int J Cancer. 2012; 131(2): 479-487.
• 51. Wu W., Tong Y., Zhao Q., Yu G., Wei X., Lu Q.: Coffee consumption and bladder cancer: a meta-analysis of observational studies. Sci Rep. 2015; doi: 10.1038/srep09051.
• 52. Yu X., Bao Z., Zou J., Dong J.: Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer. 2011; 11: 96.
• 53. Zhou Y., Tian C., Jia C.: A dose-response meta-analysis of coffee consumption and bladder cancer. Prev Med. 2012; 55(1): 14-22.
• 54. Żukiewicz-Sobczak W., Krasowska E., Sobczak P., Horach A., Wojtyła A., Piątek J.: Wpływ spożycia kawy na organizm człowieka. Medycyna Ogólna i Nauki o Zdrowiu. 2012; 18(1): 71-76.